Yakir joined Asymmetry Group after serving in Deloitte Consulting as a Managing Director in the Monitor Deloitte Strategy practice. He has worked in a variety of industries since originally joining Monitor Group in 1994, including life sciences, energy, manufacturing, construction, specialty chemicals, consumer products, telecommunications, high technology, and financial services. Within these industries, he has worked on corporate and business unit strategy, commercial capability building, marketing and organic growth strategy, stakeholder management, new business development, leadership development, and organizational design.
Yakir’s 15+ years experience in life sciences spans multiple therapeutic areas, including central nervous system, cardiovascular and metabolic, virology, oncology, hematology, urology, women’s health, and pain. His life sciences work covers the full range of the product lifecycle, from early commercial input through brand revitalization and lifecycle management and includes all aspects of integrated commercial strategy, ranging from market access and patient services to sales & marketing.
Yakir is a co-author of a number of articles on topics such as drug pricing and market access, a return on capital view of the US healthcare industry, the role of business model innovation in MedTech, and the evolving healthcare delivery landscape in the US.
Prior to joining the firm, Yakir received an A.B., A.M., and Ph.D. in Physics from Harvard University, where his research focused on ultrafast laser spectroscopy, semiconductor physics, and nonlinear optics.